Carcinoma tongue
carcinoma tongue squamous cell oral cancer
A multi-panel figure illustrating the clinical, histopathological, and radiological findings of oral squamous cell carcinoma. Panel A is a clinical photograph of the oral cavity showing a lesion on the right lateral border of the tongue. The lesion presents with an irregular, ulcerated surface and associated leukoplakia; a surgical ruler is positioned for scale, measuring approximately 7 x 10 mm. Panel B shows a histopathological section of the biopsy stained with hematoxylin and eosin (H&E) at 20x magnification. The tissue exhibits invasive nests of malignant epithelial cells with characteristic squamous differentiation and surrounding inflammatory cell infiltration, confirming squamous cell carcinoma. Panel C is an axial contrast-enhanced computed tomography (CT) scan of the head and neck. Yellow arrows highlight a hyperdense, contrast-enhancing mass on the right side of the tongue, measuring 18 mm in width and 11 mm in depth. This composite image is designed for educational use in oncology and oral surgery to demonstrate the diagnostic workflow for tongue cancer.
Intraoral clinical photograph of the left lateral tongue demonstrating an ulcerating, nodular mass approximately 3.0 cm in diameter. The lesion arises from the lingual mucosa along the left tongue margin and presents as a pink-erythematous, exophytic mass with focal surface ulceration. The patient is a 38-year-old male with over five years of chewing tobacco, a well-known risk factor for oral squamous cell carcinoma. The imaging modality is a standard white-light clinical photograph, acquired to document lesion morphology, localization, and size for baseline assessment and interdisciplinary discussion. The mass appears firm and indurated with surface irregularity and surrounding mucosal inflammation. Differential considerations include squamous cell carcinoma versus verrucous carcinoma or traumatic ulcer; however, the clinical history and lesion characteristics strongly support a malignant process. Definitive diagnosis requires histopathology from a biopsy, along with staging workup. This image is relevant for cancer screening, patient education, surgical and oncologic planning, and educational case discussions in otolaryngology/head-and-neck oncology. Keyword-rich descriptors: oral cancer, tongue cancer, oral SCC, left lateral tongue, intraoral lesion, ulcerating mass, tobacco use, risk factors, biopsy, histopathology, imaging documentation, staging, prognosis, therapy planning. Clinical images like this facilitate rapid recognition and timely management decisions. They also support patient counseling, multidisciplinary coordination, and education of trainees.
This figure illustrates the targeting of Shiga Toxin subunit B (ShTxB)-coated nanoparticles in a mouse model of oral carcinogenesis. (a) Macroscopic view of a healthy control tongue. (b) Macroscopic appearance of a tongue treated with the carcinogen 4NQO, displaying multifocal tumoral masses and leukoplakia characteristic of oral squamous cell carcinoma (OSCC). (c) Histological section (Hematoxylin and Eosin stain) of the 4NQO-treated tongue showing severe dysplasia and a focal area of invasive squamous cell carcinoma (indicated by the white arrow in inset #7). (d) Confocal immunofluorescence microscopy of a tissue cryosection demonstrating the specificity of targeted nanoparticles (PS@ShTxB). The image shows cell nuclei in blue (DAPI), the GB3 receptor—a known marker for certain HNC lesions—immunostained in red, and the green fluorescently labeled ShTxB-coated nanoparticles. The nanoparticles (green) are seen specifically clustering and coating the surface of GB3-positive (red) neoplastic lesions, highlighting the potential for targeted diagnostic imaging and therapeutic hyperthermia applications in head and neck cancer.
This composite of three clinical photographs (A, B, C) illustrates diverse clinical presentations of oral potentially malignant disorders and oral squamous cell carcinoma on the lateral border of the tongue. Panel (A) depicts erythroplasia, manifesting as a well-defined, intensely erythematous macule with an irregular, slightly granular surface texture and peripheral white striae. Panel (B) shows oral carcinoma presenting with a leukoplakia-like appearance, characterized by a thick, heterogeneous white plaque that is raised and irregular, contrasting sharply with the adjacent pink mucosa. Panel (C) demonstrates oral carcinoma with a mixed erythroleukoplakic appearance, featuring a combination of erythematous (red) and leukoplakic (white) components across the lateral tongue surface. These images serve as educational examples of incipient and established oral malignancies, highlighting the diagnostic importance of identifying persistent red, white, or mixed lesions in high-risk anatomical sites like the lateral tongue. The variations in color, texture, and border demarcation represent different clinical phenotypes within the spectrum of oral cancer development.
oral tongue squamous cell carcinoma management
Carcinoma of the Tongue
Anatomy Relevant to Tongue Cancer
- Oral tongue (anterior 2/3): The freely mobile portion, demarcated posteriorly by the circumvallate papillae (ICD-10 C02). Subdivided into tip, dorsum, lateral borders, and ventral surface.
- Base of tongue (posterior 1/3): Part of the oropharynx; generally presents at a later stage.
- Motor: Hypoglossal nerve (CN XII) - all muscles except palatoglossus (vagus, CN X)
- Sensation: Lingual nerve (branch of V3)
- Taste (anterior 2/3): Chorda tympani branch of CN VII
Epidemiology
- Oral tongue is the second most common site of oral cancer (30% of cases); in non-tobacco-chewing populations it accounts for 22-39% of oral cancers.
- Site distribution: Most tumors arise in the middle third, predominantly on the lateral border, followed by the ventral surface. Only 4-5% occur on the dorsum.
- Age: Usually presents in the 6th-8th decade; 90% of patients are over 40.
- Sex: Slightly more common in males; the male-to-female ratio has narrowed with increasing alcohol use in women.
- Risk factors: Tobacco (smoking and chewing), alcohol, immunosuppression, and possibly poor oral hygiene. Up to 70% of patients report significant tobacco and alcohol use.
- Emerging trend: Incidence in young adults (<40 years) has been increasing (from 4% in 1971 to 18% by the 1990s in the USA), often without identifiable risk factors - increased genetic susceptibility is postulated.
Clinical Presentation
Early Disease
- Erythroplakia (red inflammatory lesion) is the most common presentation of early SCC.
- Asymptomatic ulcer, lump, or persistent white patch on the lateral tongue.
- Most oral tongue cancers present at Stage I or II (unlike base of tongue tumors, which typically present at Stage III/IV).
Late/Advanced Disease
- Pain (may radiate to the ear via the lingual/auriculotemporal nerves)
- Ulceration with raised, rolled, indurated margins
- Tongue fixation (invasion of intrinsic/extrinsic muscles)
- Decreased tongue sensation
- Alteration in speech (dysarthria) and swallowing (dysphagia)
- Trismus (masseter/pterygoid involvement)
- Cervical lymphadenopathy
Cervical Metastases
- Clinically positive nodes at presentation: 21-34%
- Occult cervical metastasis: up to 53%
- Contralateral occult disease: up to 4.5%
- Tumors on the midline dorsum or ventral surface carry a greater risk of bilateral cervical node metastases
- Primary nodal drainage: upper jugular nodes (73%), submandibular (18%), middle jugular (18%), submental (9%)
Key prognostic factor: Depth of tumor invasion >2-4 mm significantly increases the risk of regional metastasis, recurrence, and mortality.
Clinical Images
Histopathology
- Vast majority are Squamous Cell Carcinoma (SCC).
- Most tongue tumors are well-to-moderately differentiated.
- Features that worsen prognosis: perineural invasion, lymphovascular invasion, positive/dysplastic margins, and advancing tumor thickness.
- Multifactorial histological malignancy grading of the invasive front helps assess cervical metastasis risk.
Staging (TNM - AJCC 8th Edition)
| T Stage | Description |
|---|---|
| T1 | Tumor ≤2 cm, depth of invasion (DOI) ≤5 mm |
| T2 | Tumor ≤2 cm with DOI >5 mm, or tumor 2-4 cm with DOI ≤10 mm |
| T3 | Tumor >4 cm, or any tumor with DOI >10 mm |
| T4a | Moderately advanced: invades cortical bone, inferior alveolar nerve, floor of mouth, or skin |
| T4b | Very advanced: invades masticator space, pterygoid plates, skull base; encases carotid |
- Depth of Invasion (DOI) was incorporated into AJCC 8th edition staging (not just tumor size), reflecting its major prognostic importance.
Workup / Investigations
- Biopsy: Most lesions are amenable to office biopsy; should include deep margin and peripheral mucosa. Deep biopsies provide tumor thickness information.
- Intraoral ultrasonography: Accurately assesses tumor thickness and aids in determining neck management.
- CT/MRI neck: To assess lymph node involvement (though sensitivity is moderate). MRI is preferred for soft tissue extent; CT for bone invasion.
- PET-CT: For advanced disease or suspected distant metastases.
- Chest imaging: To rule out pulmonary metastases and synchronous lung primaries.
- Panendoscopy: To assess for synchronous primary tumors.
Treatment
Primary Site Management
- Partial glossectomy with 1 cm margins in three dimensions is the treatment of choice.
- Reconstruction by primary closure, secondary intention, or skin graft.
- For patients unsuitable for surgery: external beam radiation ± brachytherapy.
- Ultrasonography can aid intraoperative margin assessment, particularly for the deep margin.
- Near-total or total glossectomy may be necessary.
- Glossectomy carries significant morbidity: dysphagia, aspiration; may require laryngectomy in select cases.
- For T4 with bone involvement: surgical resection ± composite resection (marginal or segmental mandibulectomy).
- Marginal mandibulectomy: For periosteal involvement.
- Segmental mandibulectomy: For medullary bone invasion (especially in edentulous patients with reduced bone stock).
- For T4: chemoradiation may be considered if surgery is not feasible.
Management of the Neck
| Depth of Invasion | Recommendation |
|---|---|
| <2 mm | Observation may be considered (though elective neck dissection gives better outcomes) |
| 2-4 mm | Elective neck dissection or radiation |
| >4 mm | Elective treatment mandatory (surgery or radiation) |
- Selective neck dissection (supraomohyoid): levels I-III minimum.
- Elective neck dissection (END) should include levels I-IV because of skip metastases.
- Bilateral neck dissections for midline tongue cancers.
- Sentinel lymph node biopsy (SLNB): Validated as feasible and accurate for T1-T2 N0 oral cavity cancers.
Adjuvant Therapy
- Post-operative radiotherapy (PORT): Indicated for positive margins, perineural invasion, lymphovascular invasion, multiple positive nodes, or extracapsular spread (ECS).
- Concurrent chemoradiotherapy (cisplatin-based): For ECS or positive margins.
Prognosis
| Stage | 5-Year Survival |
|---|---|
| Stage I-II | 60-75% |
| Stage III-IV | 25-40% |
| After salvage for regional metastasis | 35-40% |
- pN- (node negative): 5-year OS ~75%
- pN+/ECS- (node positive, no extracapsular spread): 5-year OS ~50%
- pN+/ECS+ (extracapsular spread): 5-year OS ~30%
- Tumor thickness >9 mm (5-year survival 66% vs. 100% for <3 mm)
- Perineural invasion
- Positive or dysplastic resection margins
- Cervical metastasis
- Young patients (<40 years) with tongue cancer paradoxically have a poorer long-term prognosis
Base of Tongue Carcinoma
- More commonly associated with HPV (especially p16-positive oropharyngeal SCC)
- Typically presents at Stage III/IV (later presentation)
- Often silent until advanced - first sign may be neck mass
- Management: primary chemoradiation or surgery (transoral robotic surgery, TORS)
- Better prognosis in HPV-positive cases
Key Points Summary
- Most common site: lateral border of the middle third of the oral tongue
- Erythroplakia is the earliest visible sign
- Depth of invasion is the single most important factor for neck management and prognosis
- Most oral tongue cancers present at Stage I/II - early detection is achievable
- Elective neck dissection (levels I-IV) is preferred even for clinically N0 necks when DOI >4 mm
- ECS (extracapsular spread) is a major adverse prognostic factor that mandates adjuvant chemoradiation
- Reconstruction after glossectomy must maximize residual tongue function